← Back to MYGN

Myriad Genetics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 31/07/2026Mar 2026Filed 31/07/2026Sep 2025Filed 04/11/2025Jun 2025Filed 31/07/2026Mar 2025Filed 31/07/2026Sep 2024Filed 04/11/2025Jun 2024Filed 04/11/2025Mar 2024Filed 04/11/2025
$191$200$206$213$196$213$212$202
−$43−$34−$27−$331−$0.1−$22−$37−$26
−$0.46−$0.36−$0.29−$3.57$0.00−$0.24−$0.41−$0.29
9594939391919190

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.